Barbara Birk

729 citations

26 papers · 471 indexed · h-index 8

Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 7
Endocrinology, Diabetes and Metabolism top 10%
- Hormonal Regulation and Hypertension 7
- Thyroid Disorders and Treatments 5
Genetics
- Estrogen and related hormone effects 3
Health, Toxicology and Mutagenesis
- Effects and risks of endocrine disrupting chemicals 3
Organic Chemistry
Computational Theory and Mathematics
- Computational Drug Discovery Methods 5
Molecular Biology
- Metabolomics and Mass Spectrometry Studies 4
Small Animals
- Animal testing and alternatives 2

Co-authors: Rolf W. Hartmann Matthias Negri Simon Lucas Ralf Heim Robert Landsiedel Sandrine Marchais‐Oberwinkler Martin Frotscher Patricia Kruchten
Cited by: Pharmacology Endocrinology, Diabetes and Metabolism Genetics
Journals: Journal of Medicinal Chemistry (4 papers)Archives of Toxicology (3 papers)Toxicology Letters (3 papers)
Partner nations: Germany United States Italy

In The Last Decade

Barbara Birk

22 papers receiving 466 citations

Peers

Countries citing papers authored by Barbara Birk

Since Specialization

Citations

This map shows the geographic impact of Barbara Birk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Birk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Birk more than expected).

Fields of papers citing papers by Barbara Birk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Birk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Birk. The network helps show where Barbara Birk may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Barbara Birk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Birk Line = papers co-authored together Barbara Birk links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cross-taxa extrapolation: Is there a role for thyroid hormone conjugating liver enzymes during amphibian metamorphosis? Regulatory Toxicology and Pharmacology ·Megan E. Wilson,Christos Tzavelas,Barbara Birk,Nicola J. Hewitt,Lennart Weltje,Park Jin-Byoung	2025	0
2	The Use of Toxicokinetic Information for Setting Concentrations of In Vitro Toxicity Tests and for Interpreting Their Results: A Proposed Workflow Robert Landsiedel,Barbara Birk,Laura Hollsten,Eric Fabian,Nicola J. Hewitt,Heli M. Hollnagel,Julia Scheel	2024	2
3	Molecular signatures of angiogenesis inhibitors: a single-embryo untargeted metabolomics approach in zebrafish Archives of Toxicology ·F. Vadidar,Volker Haake,Franziska Maria Zickgraf,А. Г. Антипьев,Philipp Ternes,D. A. Douglas,東谷邦子,Stefan Scholz,Marta Barenys,Burkhard Flick,Barbara Birk,Hennicke Kamp,Robert Landsiedel,Thierry Hoet	2024	0
4	Limitations and Modifications of Skin Sensitization NAMs for Testing Inorganic Nanomaterials Toxics ·Mahalaxmi Laxman,魚嶋伸彦,Susanne N. Kolle,Barbara Birk,Thierry Hoet,Josué Leal Moura Dantas	2024	3
5	Application of high throughput in vitro metabolomics for hepatotoxicity mode of action characterization and mechanistic-anchored point of departure derivation: a case study with nitrofurantoin Archives of Toxicology ·S. Niel,Barbara Birk,Philipp Ternes,А. Г. Антипьев,Franziska Maria Zickgraf,Volker Haake,Michael Herold,Hennicke Kamp,D. A. Douglas,Robert Landsiedel,Elke Richling,Thierry Hoet,Bennard van Ravenzwaay	2023	4
6	Assessment of the Predictivity of DIO1-SK Assay to Investigate DIO1 Inhibition in Human Liver Microsomes Shilpakala Lb,Barbara Birk,А. Г. Антипьев,Sebastian Hoffmann,Kostja Renko,Sandra Coecke,Steffen Schneider,Thierry Hoet,Robert Landsiedel	2023	1
7	A high-throughput metabolomics in vitro platform for the characterization of hepatotoxicity Cell Biology and Toxicology ·S. Niel,Barbara Birk,Philipp Ternes,А. Г. Антипьев,Volker Haake,Michael Herold,Franziska Maria Zickgraf,Samer El-Aabd,K. Feind,Hennicke Kamp,D. A. Douglas,Robert Landsiedel,Elke Richling,Thierry Hoet,Bennard van Ravenzwaay	2023	3
8	A metabolomics approach to reveal the mechanism of developmental toxicity in zebrafish embryos exposed to 6-propyl-2-thiouracil Chemico-Biological Interactions ·F. Vadidar,А. Г. Антипьев,Franziska Maria Zickgraf,Volker Haake,Lars Vorthoren,D. A. Douglas,NS Koide,Wibke Busch,Stefan Scholz,Burkhard Flick,Marta Barenys,Barbara Birk,Hennicke Kamp,Robert Landsiedel,Thierry Hoet	2023	6
9	A New Approach Method to Study Thyroid Hormone Disruption: Optimization and Standardization of an Assay to Assess the Inhibition of DIO1 Enzyme in Human Liver Microsomes Shilpakala Lb,Barbara Birk,Maria Silva Pinto Ribeiro da Cunha,K. Feind,Kostja Renko,Sandra Coecke,Steffen Schneider,Thierry Hoet,Robert Landsiedel	2022	6
10	The Evolution of Regulatory Toxicology: Where is the Gardener? Alternatives to Laboratory Animals ·Robert Landsiedel,Barbara Birk,Thierry Hoet	2022	7
11	Use of in vitro metabolomics in NRK cells to help predicting nephrotoxicity and differentiating the MoA of nephrotoxicants Toxicology Letters ·Barbara Birk,Volker Haake,Saskia Sperber,Michael Herold,Luisa Rezende Faber,K. Feind,Samer El-Aabd,Mike Fabjanczyk,Tilmann Walk,Mohamed Tighezza,Nicola J. Hewitt,Hennicke Kamp,Bennard van Ravenzwaay	2021	4
12	The thyroid hormone converting enzyme human deiodinase 1 is inhibited by gold ions from inorganic salts, organic substances, and by small-size nanoparticles Chemico-Biological Interactions ·Shilpakala Lb,Barbara Birk,Kobayashi Chieka,Steffen Schneider,Bennard van Ravenzwaay,Thierry Hoet,Robert Landsiedel	2021	5
13	Optimization of the Thyroid Receptor, TRβ CALUX, Assay: Specific Control Compounds and Appropriate Cell Viability Assays Toxicology Letters ·Shilpakala Lb,Barbara Birk,K Kudo,S. Schneider,Thierry Hoet,B. van Ravenzwaay,Robert Landsiedel	2021	0
14	In Silico Models to Predict the Perturbation of Molecular Initiating Events Related to Thyroid Hormone Homeostasis Chemical Research in Toxicology ·Heryati Heryati,Shilpakala Lb,Barbara Birk,Robert Landsiedel,Janosch Achenbach,LUCIANA HADDAD FERREIRA,Miriam Mathea,Johannes Kirchmair	2020	39
15	A mode-of-action ontology model for safety evaluation of chemicals: Outcome of a series of workshops on repeated dose toxicity Toxicology in Vitro ·Bertrand Desprez,Barbara Birk,Bas J. Blaauboer,Alan R. Boobis,Paul L. Carmichael,M Cronin,Shuangli Song,George P. Daston,Bruno Hubesch,Paul Jennings,Martina Klarić,Dinant Kroese,Catherine Mahony,Gladys Ouédraogo,Aldert H. Piersma,Mohammed Abdul Alhussien,Michael Schwarz,Jan van Benthem,Bob van de Water,Mathieu Vinken	2019	17
16	In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds Archives of Toxicology ·Eric Fabian,Francis D. Feeney,Barbara Birk,Afaf Abdel Alim,Mohamed Tighezza,Christian Haase,Diana Musyoka,Bennard van Ravenzwaay,Robert Landsiedel	2018	61
17	Selective aldosterone synthase inhibitors reduce aldosterone formation in vitro and in vivo The Journal of Steroid Biochemistry and Molecular Biology ·Betty P. Teng,Simon Lucas,Ralf Heim,Barbara Birk,Rolf W. Hartmann	2009	18
18	Design, Synthesis, Biological Evaluation and Pharmacokinetics of Bis(hydroxyphenyl) substituted Azoles, Thiophenes, Benzenes, and Aza-Benzenes as Potent and Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) Journal of Medicinal Chemistry ·Emmanuel Bey,Sandrine Marchais‐Oberwinkler,Ruth Werth,Matthias Negri,Yaseen A. Al‐Soud,Patricia Kruchten,Alexander Oster,Martin Frotscher,Barbara Birk,Rolf W. Hartmann	2008	100
19	In Vivo Active Aldosterone Synthase Inhibitors with Improved Selectivity: Lead Optimization Providing a Series of Pyridine Substituted 3,4-Dihydro-1H-quinolin-2-one Derivatives Journal of Medicinal Chemistry ·Simon Lucas,Ralf Heim,Betty P. Teng,三佳中島,Barbara Birk,Rolf W. Hartmann	2008	69
20	Thrombin causes the Enrichment of Rat Brain Primary Cultures with Ependymal Cells Via Protease-Activated Receptor 1 Neurochemical Research ·Felix Tritschler,Radovan Murín,Barbara Birk,Jürgen Berger,P.P.W. Law,Bernd Hamprecht,Stephan Verleysdonk	2007	6

About Barbara Birk

Barbara Birk is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism, Biological Psychiatry, Health, Toxicology and Mutagenesis and Computational Theory and Mathematics, having authored 26 papers that have together received 471 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Hormonal Regulation and Hypertension (7 papers), Computational Drug Discovery Methods (5 papers), Thyroid Disorders and Treatments (5 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Effects and risks of endocrine disrupting chemicals (3 papers), Estrogen and related hormone effects (3 papers) and Animal testing and alternatives (2 papers). The work is most often cited by research in Pharmacology (97 citations), Endocrinology, Diabetes and Metabolism (180 citations), Genetics (131 citations), Health, Toxicology and Mutagenesis (58 citations) and Organic Chemistry (115 citations). Barbara Birk has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Rolf W. Hartmann, Matthias Negri, Simon Lucas, Ralf Heim, Robert Landsiedel, Sandrine Marchais‐Oberwinkler, Martin Frotscher, Patricia Kruchten, Alexander Oster and Ruth Werth. Their work appears in journals such as Journal of Medicinal Chemistry, Archives of Toxicology, Toxicology Letters, Chemico-Biological Interactions and ALTEX.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact